These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 19482862)
1. T2' imaging indicates decreased tissue metabolism in frontal white matter of MS patients. Holst B; Siemonsen S; Finsterbusch J; Bester M; Schippling S; Martin R; Fiehler J Mult Scler; 2009 Jun; 15(6):701-7. PubMed ID: 19482862 [TBL] [Abstract][Full Text] [Related]
2. Magnetization transfer can predict clinical evolution in patients with multiple sclerosis. Santos AC; Narayanan S; de Stefano N; Tartaglia MC; Francis SJ; Arnaoutelis R; Caramanos Z; Antel JP; Pike GB; Arnold DL J Neurol; 2002 Jun; 249(6):662-8. PubMed ID: 12111296 [TBL] [Abstract][Full Text] [Related]
3. A magnetization transfer MRI study of deep gray matter involvement in multiple sclerosis. Sharma J; Zivadinov R; Jaisani Z; Fabiano AJ; Singh B; Horsfield MA; Bakshi R J Neuroimaging; 2006 Oct; 16(4):302-10. PubMed ID: 17032378 [TBL] [Abstract][Full Text] [Related]
4. Differential changes in deep and cortical gray matters of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Zhou F; Zee CS; Gong H; Shiroishi M; Li J J Comput Assist Tomogr; 2010; 34(3):431-6. PubMed ID: 20498549 [TBL] [Abstract][Full Text] [Related]
5. T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis. Ceccarelli A; Filippi M; Neema M; Arora A; Valsasina P; Rocca MA; Healy BC; Bakshi R Mult Scler; 2009 Jun; 15(6):678-86. PubMed ID: 19482861 [TBL] [Abstract][Full Text] [Related]
6. Brain iron deposition fingerprints in Parkinson's disease and progressive supranuclear palsy. Boelmans K; Holst B; Hackius M; Finsterbusch J; Gerloff C; Fiehler J; Münchau A Mov Disord; 2012 Mar; 27(3):421-7. PubMed ID: 22290788 [TBL] [Abstract][Full Text] [Related]
7. Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease. Vrenken H; Pouwels PJ; Ropele S; Knol DL; Geurts JJ; Polman CH; Barkhof F; Castelijns JA Mult Scler; 2007 Jul; 13(6):708-16. PubMed ID: 17613597 [TBL] [Abstract][Full Text] [Related]
8. Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis. Ceccarelli A; Rocca MA; Neema M; Martinelli V; Arora A; Tauhid S; Ghezzi A; Comi G; Bakshi R; Filippi M Mult Scler; 2010 Jan; 16(1):39-44. PubMed ID: 19965516 [TBL] [Abstract][Full Text] [Related]
9. Iron deposition in the precentral grey matter in patients with multiple sclerosis: a quantitative study using susceptibility-weighted imaging. Rumzan R; Wang JJ; Zeng C; Chen X; Li Y; Luo T; Lv F; Wang ZP; Hou H; Huang F Eur J Radiol; 2013 Feb; 82(2):e95-9. PubMed ID: 23079047 [TBL] [Abstract][Full Text] [Related]
10. Gray matter atrophy in multiple sclerosis: a longitudinal study. Fisher E; Lee JC; Nakamura K; Rudick RA Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561 [TBL] [Abstract][Full Text] [Related]
11. T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis. Neema M; Stankiewicz J; Arora A; Dandamudi VS; Batt CE; Guss ZD; Al-Sabbagh A; Bakshi R J Neuroimaging; 2007 Apr; 17 Suppl 1():16S-21S. PubMed ID: 17425729 [TBL] [Abstract][Full Text] [Related]
12. Water content and myelin water fraction in multiple sclerosis. A T2 relaxation study. Laule C; Vavasour IM; Moore GR; Oger J; Li DK; Paty DW; MacKay AL J Neurol; 2004 Mar; 251(3):284-93. PubMed ID: 15015007 [TBL] [Abstract][Full Text] [Related]
13. Reduced R2' in multiple sclerosis normal appearing white matter and lesions may reflect decreased myelin and iron content. Paling D; Tozer D; Wheeler-Kingshott C; Kapoor R; Miller DH; Golay X J Neurol Neurosurg Psychiatry; 2012 Aug; 83(8):785-92. PubMed ID: 22626944 [TBL] [Abstract][Full Text] [Related]
14. Deep grey matter "black T2" on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis. Zhang Y; Zabad R; Wei X; Metz L; Hill M; Mitchell J Mult Scler; 2007 Aug; 13(7):880-3. PubMed ID: 17468444 [TBL] [Abstract][Full Text] [Related]
15. Quantitative T2' imaging in patients with clinically isolated syndrome. Reitz LY; Inglese M; Fiehler J; Finsterbusch J; Holst B; Heesen C; Martin R; Schippling S Acta Neurol Scand; 2012 Nov; 126(5):357-63. PubMed ID: 22211987 [TBL] [Abstract][Full Text] [Related]
16. Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis - A longitudinal voxel-based morphometry study. Bendfeldt K; Kuster P; Traud S; Egger H; Winklhofer S; Mueller-Lenke N; Naegelin Y; Gass A; Kappos L; Matthews PM; Nichols TE; Radue EW; Borgwardt SJ Neuroimage; 2009 Mar; 45(1):60-7. PubMed ID: 19013533 [TBL] [Abstract][Full Text] [Related]
17. Abnormal diffusivity of normal appearing brain tissue in multiple sclerosis: a diffusion-weighted MR imaging study. Phuttharak W; Galassi W; Laopaiboon V; Laopaiboon M; Hesselink JR J Med Assoc Thai; 2007 Dec; 90(12):2689-94. PubMed ID: 18386722 [TBL] [Abstract][Full Text] [Related]
18. Cerebral white matter blood flow and energy metabolism in multiple sclerosis. Steen C; D'haeseleer M; Hoogduin JM; Fierens Y; Cambron M; Mostert JP; Heersema DJ; Koch MW; De Keyser J Mult Scler; 2013 Sep; 19(10):1282-9. PubMed ID: 23428956 [TBL] [Abstract][Full Text] [Related]
19. Connecting white matter injury and thalamic atrophy in clinically isolated syndromes. Henry RG; Shieh M; Amirbekian B; Chung S; Okuda DT; Pelletier D J Neurol Sci; 2009 Jul; 282(1-2):61-6. PubMed ID: 19394969 [TBL] [Abstract][Full Text] [Related]